Genfit: positive results from a LOW4 test

Genfit announced results from a study demonstrating that NIS4, a non-invasive blood diagnostic tool developed for the diagnosis of non-alcoholic steatohepatitis (NASH), performed better than other non-invasive tools in the diagnosis of NASH...

Genfit: positive results from a LOW4 test

Genfit announced results from a study demonstrating that NIS4, a non-invasive blood diagnostic tool developed for the diagnosis of non-alcoholic steatohepatitis (NASH), performed better than other non-invasive tools in the diagnosis of NASH in patients with type 2 diabetes. These results were presented on November 10 at the AASLD 2019 Liver Meeting in Boston, Massachusetts.

The post Genfit: positive results from a LOW4 test appeared first on Born2Invest.